Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dallas J Smith

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Pharmaceutical Biology|November 19, 2025
An exploratory evaluation of the interaction risk between herbal products and pharmaceutical medicines used concurrently for disease management in Blantyre, MalawiKumbukani K Nyirenda, John Mponda, Ibrahim Chikowe, et al.
MMWR. Morbidity and Mortality Weekly Report|February 12, 2026
Pseudo-Outbreak of Purpureocillium lilacinum Skin Infections at a Dermatology Clinic - Washington, 2024Kyle S Yomogida, Emily Laskowski, Lisa Hannah, et al.
The New England Journal of Medicine|February 7, 2024
Neurovascular Complications of Iatrogenic <i>Fusarium solani</i> MeningitisNora Strong, Grant Meeks, Sunil A Sheth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Update on Outbreak of Fungal Meningitis Among US Residents Who Received Epidural Anesthesia at Two Clinics in Matamoros, MexicoDallas J Smith, Jeremy A W Gold, Tom Chiller, et al.
Journal of Clinical Microbiology|April 4, 2025
Establishment of epidemiological cutoff values for <i>Fonsecaea pedrosoi</i>, the primary etiologic agent of chromoblastomycosis, and eight antifungal medicationsDallas J Smith, Marcia S C Melhem, Jessy Dirven, et al.
JAMA Dermatology|May 15, 2024
Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineaeAvrom S Caplan, Gabrielle C Todd, YanChun Zhu, et al.
Medical Mycology|May 14, 2024
Proceedings of the second international meeting on endemic mycoses of the Americas (IMEMA) and first international symposium on implantation mycoses (ISIM)Norma B Fernandez, Diego H Cáceres, Julian A Serrano, et al.
Plos Neglected Tropical Diseases|October 15, 2024
A global chromoblastomycosis strategy and development of the global chromoblastomycosis working groupDallas J Smith, Flávio Queiroz-Telles, Fahafahantsoa Rapelanoro Rabenja, et al.
Emerging Infectious Diseases|April 3, 2025
Metagenomic Identification of Fusarium solani Strain as Cause of US Fungal Meningitis Outbreak Associated with Surgical Procedures in Mexico, 2023Charles Y Chiu, Venice Servellita, Mikael de Lorenzi-Tognon, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 16, 2024
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitisIsabel S Griffin, Dallas J Smith, Pallavi Annambhotla, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Pharmaceutical Biology|November 19, 2025
An exploratory evaluation of the interaction risk between herbal products and pharmaceutical medicines used concurrently for disease management in Blantyre, MalawiKumbukani K Nyirenda, John Mponda, Ibrahim Chikowe, et al.
MMWR. Morbidity and Mortality Weekly Report|February 12, 2026
Pseudo-Outbreak of Purpureocillium lilacinum Skin Infections at a Dermatology Clinic - Washington, 2024Kyle S Yomogida, Emily Laskowski, Lisa Hannah, et al.
The New England Journal of Medicine|February 7, 2024
Neurovascular Complications of Iatrogenic <i>Fusarium solani</i> MeningitisNora Strong, Grant Meeks, Sunil A Sheth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Update on Outbreak of Fungal Meningitis Among US Residents Who Received Epidural Anesthesia at Two Clinics in Matamoros, MexicoDallas J Smith, Jeremy A W Gold, Tom Chiller, et al.
Journal of Clinical Microbiology|April 4, 2025
Establishment of epidemiological cutoff values for <i>Fonsecaea pedrosoi</i>, the primary etiologic agent of chromoblastomycosis, and eight antifungal medicationsDallas J Smith, Marcia S C Melhem, Jessy Dirven, et al.
JAMA Dermatology|May 15, 2024
Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineaeAvrom S Caplan, Gabrielle C Todd, YanChun Zhu, et al.
Medical Mycology|May 14, 2024
Proceedings of the second international meeting on endemic mycoses of the Americas (IMEMA) and first international symposium on implantation mycoses (ISIM)Norma B Fernandez, Diego H Cáceres, Julian A Serrano, et al.
Plos Neglected Tropical Diseases|October 15, 2024
A global chromoblastomycosis strategy and development of the global chromoblastomycosis working groupDallas J Smith, Flávio Queiroz-Telles, Fahafahantsoa Rapelanoro Rabenja, et al.
Emerging Infectious Diseases|April 3, 2025
Metagenomic Identification of Fusarium solani Strain as Cause of US Fungal Meningitis Outbreak Associated with Surgical Procedures in Mexico, 2023Charles Y Chiu, Venice Servellita, Mikael de Lorenzi-Tognon, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 16, 2024
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitisIsabel S Griffin, Dallas J Smith, Pallavi Annambhotla, et al.
Pageof 7